soothing and repair lip care

1. INCI & CAS

INCI: Glycerin · CAS: 56-81-5

2. Role in the formula

This entry describes glycerin as a polyol humectant for gels, emulsions, and washes, with a guide level rather than a batch result.

3. Typical use levels (formulation guide)

• For gels and serums, the reference gives 3–8% in this reference.
• The stated reference for creams is 2–5% in this reference.
• The rinse-off use-level reference is 2–4%.

The water phase is the addition point for Glycerin; a separate melt is unnecessary.

4. Regulatory sources & global compliance

• Treat any CosIng entry for Glycerin as a reference only; verify the grade and intended use under current market rules.
• The framework in Regulation (EC) No 1223/2009 requires a safety assessment of the finished cosmetic containing Glycerin in the final product context.
• Use the supplier TDS to confirm grade-specific details for Glycerin and review the destination market's requirements.

5. Safety & risk assessment

The percentage is shown for cosmetic development; it does not qualify a finished product as a drug or OTC product and the finished formula still needs patch and stability testing.

6. Stability & packaging

Hold the bulk material in a sealed, cool place shielded from light; where appropriate, assess an airless or pump pack for oxidation-sensitive systems; check the final package and formula together for compatibility and stability.

7. Claims language (Do / Don’t)

• The formulation note describes Glycerin as part of a cosmetic direction focused on humectant function.

• This formulation entry does not demonstrate therapeutic effects, curative outcomes, or unsupported certification statements.
• The cosmetic guidance for Glycerin cannot verify a skin-lightening result, acne treatment, antiperspirant action, sunscreen efficacy, or hair growth.

1. INCI & CAS

INCI: Squalane · CAS: 111-01-3

2. Role in the formula

Squalane provides the referenced hydrocarbon-emollient role in a plant-derived grade; mineral oil is not part of this guide.

3. Typical use levels (formulation guide)

• Gel-creams: 2–6% as a formulation guide.
• For dry oils, use 10–30%.
• For balms, use 5–15% as a formulation guide.

Use the oil phase to introduce Squalane; a high-shear wax stage is not specified.

4. Regulatory sources & global compliance

• CosIng information about Squalane does not itself authorize a particular grade or finished cosmetic.
• For an EU-market product, Regulation (EC) No 1223/2009 requires the final cosmetic with Squalane to undergo a safety assessment as part of the finished cosmetic's safety documentation.
• Check the supplier's technical information for the Squalane grade and confirm the relevant market filing list.

5. Safety & risk assessment

The listed use rate is intended as a cosmetic-development guide; it makes no claim of drug or OTC authorization and the completed cosmetic needs its own patch and stability checks.

6. Stability & packaging

Store sealed bulk away from heat and sunlight; where oxidation is a concern, evaluate airless or pump packaging; follow with stability and packaging checks on the confirmed batch.

7. Claims language (Do / Don’t)

• The recorded cosmetic positioning for Squalane highlights a light-emollient role.

• This reference provides no basis for drug claims, cure claims, or a certification that is absent from the product records.
• The available details for Squalane is not evidence for whitening, acne care as treatment, perspiration reduction, sun protection, or hair growth.

1. INCI & CAS

INCI: Butyrospermum Parkii Butter · CAS: 91080-23-8

2. Role in the formula

In creams, balms, and hair creams, shea butter is the cushion-providing triglyceride butter. No unrefined appearance or scent is specified.

3. Typical use levels (formulation guide)

• The stated reference for creams is 2–8%.
• For balms and butters, the reference gives 10–25% as a formulation guide.

The process note calls for melting Butyrospermum Parkii Butter into oil and cooling with shear so the butter does not grain.

4. Regulatory sources & global compliance

• The CosIng record for Butyrospermum Parkii Butter, where listed, is informational rather than product-specific authorization.
• An EU-market cosmetic under Regulation (EC) No 1223/2009 requires the completed product containing Butyrospermum Parkii Butter to receive its own safety assessment for the product in its final form.
• Verify the purchased Butyrospermum Parkii Butter grade using supplier data, alongside the applicable filing rules for the destination market.

5. Safety & risk assessment

This formulation note gives a cosmetic-use reference level; it is not evidence of drug approval or OTC authorization so the finished cosmetic should receive patch and stability checks.

6. Stability & packaging

For bulk storage, avoid warmth and direct sun and keep the container closed; review airless or pump options if oxidation presents a concern; verify the chosen pack against the tested formula.

7. Claims language (Do / Don’t)

• The listed cosmetic direction for Butyrospermum Parkii Butter emphasizes shea cushion.

• The cosmetic listing does not substantiate therapeutic effects, curative outcomes, or unsupported certification statements.
• The information about Butyrospermum Parkii Butter is not evidence for a whitening effect, acne treatment, perspiration control, sun protection, or hair growth.